你即將離開本站

並前往https://adisinsight.springer.com/drugs/800021154

Neratinib - Puma Biotechnology - AdisInsight

In March 2020, neratinib was approved in Switzerland as an extended adjuvant treatment of HER2+ breast cancer . In June 2021, the US FDA approved a labeling ...

確定！ 回上一頁

查詢 「Neratinib」的人也找了：

  1. neratinib中文
    2.
  2. neratinib台灣
    3.
  3. neratinib藥廠
    4.
  4. neratinib健保
    5.
  5. neratinib乳癌
    6.
  6. 乳癌治療指引2020
    7.
  7. neratinib副作用
    8.
  8. nerlynx中文
    9.